The Discounted Cash Flow (DCF) valuation of Mouwasat Medical Services Company SJSC (4002.SR) is 38.71 SAR. With the latest stock price at 76.25 SAR, the upside of Mouwasat Medical Services Company SJSC based on DCF is -49.2%.
Based on the latest price of 76.25 SAR and our DCF valuation, Mouwasat Medical Services Company SJSC (4002.SR) is a sell. selling 4002.SR stocks now will result in a potential gain of 49.2%.
| Range | Selected | |
| WACC / Discount Rate | 12.3% - 14.7% | 13.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 33.07 - 46.97 | 38.71 |
| Upside | -56.6% - -38.4% | -49.2% |